Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
04/29/2009 | CN101418034A Method for extracting jatropha curcas seed oil protein |
04/29/2009 | CN100482679C Process of purification of hCG and recombinant hCG purified by that method |
04/29/2009 | CN100482678C Protein treatment process |
04/29/2009 | CN100482677C Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
04/29/2009 | CN100482277C Calicheamicin derivative-carrier conjugates |
04/28/2009 | US7524940 OB protein compositions and methods |
04/28/2009 | US7524932 Lactalbumin production process |
04/28/2009 | US7524925 Protein interaction reporter agents and methods for using same |
04/28/2009 | US7524821 Scaffolded maleimide clusters for multivalent peptide assembly |
04/28/2009 | US7524813 Selectively conjugated peptides and methods of making the same |
04/28/2009 | US7524663 immunogens and epitopes used for treatment of autoimmune diseases; catalytic antibodies |
04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
04/28/2009 | CA2133017C Process for producing desired substance using acetic acid-resistant recombinant escherichia microorganism |
04/23/2009 | WO2009051797A1 Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
04/23/2009 | WO2009050319A1 Scalable process for producing phycocyanine |
04/23/2009 | WO2009050266A2 Use of n-terminal and c-terminal proteomics technology to enhance protein therapeutics and diagnostics |
04/23/2009 | WO2009050261A1 Preparation of samples for proteome analysis |
04/23/2009 | WO2009032181A3 Methods and intermediates for chemical synthesis of polypeptides and proteins |
04/23/2009 | WO2009024620A3 A process for isolation and purification of a target protein free of prion protein (prpsc) |
04/23/2009 | WO2008140477A8 Hybrid immunoglobulins with moving parts |
04/23/2009 | WO2007138198A3 Method for the extraction of one or several proteins present in milk |
04/23/2009 | WO2007086889A3 Tropoelastin isoforms and uses thereof |
04/23/2009 | WO2007056218A3 Heparan sulfate glycosaminoglycan lyase and uses thereof |
04/23/2009 | WO2007055966A3 Therapies for cancer using rlip76 |
04/23/2009 | WO2007014170A3 Compositions and methods for protein deaggregation |
04/23/2009 | WO2006135886A3 Compositions and methods for treating and diagnosing cancer |
04/23/2009 | WO2006133333A3 Stimulation of pancreatic b cell proliferation |
04/23/2009 | WO2006076467A3 Treatment of pre-eclampsia in pregnant women using targeted apheresis |
04/23/2009 | WO2006052821A3 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
04/23/2009 | WO2005103279A3 Synthetic genes |
04/23/2009 | US20090105465 Protein Purification Using HCIC and Ion Exchange Chromatography |
04/23/2009 | US20090105464 Physiologically active polypeptide and dna |
04/23/2009 | US20090105455 Purified interleukin-15/fc fusion protein and preparation thereof |
04/23/2009 | US20090105452 Non-fluorescent quencher compounds and biomolecular assays |
04/23/2009 | US20090105451 Use of aqueous wettable hydrophobic chromatographic media for the purification of peptides, and other biomolecules |
04/23/2009 | US20090105450 Use of modified metal oxides for enrichment of phosphopeptides |
04/23/2009 | US20090105193 Crosslinked compounds and methods of making and using thereof |
04/23/2009 | US20090105134 C-Terminally Pegylated Growth Hormones |
04/23/2009 | US20090105131 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
04/23/2009 | US20090105120 Method for preparing tryptophan rich peptides |
04/23/2009 | US20090105119 Asparagine-10-substituted nonadepsipeptides |
04/23/2009 | US20090104678 Method of producing polysaccharide derivatives |
04/23/2009 | US20090104606 Late gestation lung genes, fragments and uses thereof |
04/23/2009 | US20090104195 Targeted ligands |
04/23/2009 | US20090104173 Novel process for solubilizing protein from a proteinaceous material and compositions thereof |
04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
04/23/2009 | US20090101491 Methods and apparatus for rapid crystallization of biomolecules |
04/23/2009 | CA2709679A1 Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
04/22/2009 | EP2049691A2 Crohn disease susceptibility gene |
04/22/2009 | EP2049561A1 Process for the manufacture of peptides |
04/22/2009 | EP2049560A1 Process for preparing particles of proteinaceous material |
04/22/2009 | EP2049144A2 Glycosylation of peptides via o-linked glycosylation sequences |
04/22/2009 | EP1969371A4 A method of producing a multimeric capture agent for binding a ligand |
04/22/2009 | EP1651664B1 Ligation method |
04/22/2009 | EP1641819B1 Purification of her-2 variants |
04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
04/22/2009 | EP1214088B1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
04/22/2009 | CN101415727A Binder for C-reactive protein |
04/22/2009 | CN101415722A A method for the preparation of K-carrageenase |
04/22/2009 | CN101415721A Compositions for purifying and crystallizing molecules of interest |
04/22/2009 | CN101413143A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
04/22/2009 | CN101413019A Preparation of casein glycomacmpepride |
04/22/2009 | CN101412755A Solid phase synthesis method for thymosin beta 4 |
04/22/2009 | CN101412752A Solid phase synthesis method of ziconotide |
04/22/2009 | CN101412747A Novel cell-penetrating peptide and uses thereof |
04/22/2009 | CN101412746A Preparation of feather protein film |
04/22/2009 | CN100480374C Process for preparing recombination human glicentin-1(7-37) |
04/22/2009 | CN100480270C Fusion protein of chemoattracting small peptide and dual specific antibodies |
04/22/2009 | CN100480258C Purified LH (Luteinizing hormone) |
04/22/2009 | CN100479930C Biological control of nanoparticles |
04/22/2009 | CN100479675C Gelling vegetable protein |
04/21/2009 | US7522162 Light harvesting optical, optoelectronic, and photovoltaic devices |
04/21/2009 | US7521539 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
04/21/2009 | US7521534 IKK gamma gene products and methods for making and using same |
04/21/2009 | US7521531 Methods for the purification of stable radioiodine conjugates |
04/21/2009 | US7521529 Lantibiotics; biosynthesis; solid phase synthesis; deblocking, deprotecting |
04/21/2009 | US7521421 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
04/21/2009 | US7521420 Macrocyclic antagonists of the motilin receptor |
04/21/2009 | US7521417 Method and apparatus for preparing an acellular red blood cell substitute |
04/21/2009 | US7521235 Unique novel Bacillus thuringiensis gene with Lepidopteran activity |
04/21/2009 | US7521223 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferases for use in enhancing omega fatty acids production in yarrowia |
04/21/2009 | US7521202 Generating soluble human leukocyte antigens in cells from genomic DNA or cDNA, for prevention of viral, bacterial and proliferative disorders; polymerase chain reaction |
04/21/2009 | US7521046 Antibody immunization therapy for treatment of atherosclerosis |
04/16/2009 | WO2009048343A1 Functional lipid constructs |
04/16/2009 | WO2009046918A1 Use of layered double hydroxides for the enrichment or depletion of biomolecules from liquid or fluid media |
04/16/2009 | WO2009046840A1 Method and agent for refolding proteins |
04/16/2009 | WO2009046520A1 A fusion tag comprising an affinity tag and an ef-hand motif containing polypeptide and methods of use thereof |
04/16/2009 | WO2009027707A3 Methods for preparing peptides, especially radio-labelled peptides |
04/16/2009 | WO2008150023A3 Method for producing antagonist of growth factor |
04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
04/16/2009 | WO2008035222A3 Synthesis of carbohydrate-templated amino acids and methods of using same |
04/16/2009 | WO2008028002A9 Increasing nadph-dependent products |
04/16/2009 | WO2008027252A3 Poxvirus ifn- ybp c-terminal domain |
04/16/2009 | WO2007113819A3 Methods and compositions for preventing and treating streptococcus pneumoniae infection |
04/16/2009 | WO2006102547A3 Method for purifying proteins |
04/16/2009 | WO2006096704A3 Isotopically-labeled proteome standards |
04/16/2009 | WO2006089095A3 Treating neurological disorders |
04/16/2009 | WO2006032016A3 P49/strap is a novel protein involved in gene regulation and cell proliferation |
04/16/2009 | WO2006009676A3 Compositions and methods for enzymatic decolorization of chlorophyll |
04/16/2009 | WO2005094393A3 Methods and processes for attaching compounds to matrices |